COLL
Collegium Pharmaceutical Inc
23.80$
-1.0%
vs. previous close
Closing price · As of: Oct 30, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Collegium Pharmaceutical Inc (COLL) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 10/19/2026 | Current report (8-K) | COLLEGIUM PHARMACEUTICAL, INC (COLL): Termination of a Material Definitive Agreement | View report ↗ |
| 09/30/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 08/24/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 08/14/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 08/13/2026 | Current report (8-K) | COLLEGIUM PHARMACEUTICAL, INC (COLL): Other Events | View report ↗ |
| 08/06/2026 | Current report (8-K) | COLLEGIUM PHARMACEUTICAL, INC (COLL): Results of Operations and Financial Condition; Regulation FD Disclosure | View report ↗ |
| 08/05/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 07/31/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 07/17/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 07/15/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.